Finance

Lists
INNO:CNSX
Innocan Pharma Corp
CA$2.30
-2.13%
(-0.050) 1D
Sep 4, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for INNO...
Open
CA$2.30
High
CA$2.30
Low
CA$2.30
Mkt. cap
10.38M
Avg. vol.
2.33K
Volume
600.00
52-wk high
CA$21.00
52-wk low
CA$2.00
EPS
-CA$0.29
No. of employees
8
Open
CA$2.30
High
CA$2.30
Low
CA$2.30
Mkt. cap
10.38M
Avg. vol.
2.33K
Volume
600.00
52-wk high
CA$21.00
52-wk low
CA$2.00
EPS
-CA$0.29
No. of employees
8
About Innocan Pharma Corp
CEO-
Employees8
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteinnocanpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.82M
4.99M
6.46M
5.25M
Cost of goods sold
631.00K
558.00K
575.00K
481.00K
Cost of revenue
631.00K
558.00K
575.00K
481.00K
Research and development expenses
415.00K
161.00K
184.00K
-9.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.99M
5.19M
6.49M
5.29M
Operating expense
7.41M
5.35M
6.68M
5.28M
Total operating expenses
8.04M
5.91M
7.25M
5.76M
Operating income
-1.22M
-922.00K
-786.00K
-508.00K
Other non operating income
-200.00K
1.93M
7.00K
340.00K
EBT including unusual items
-1.43M
1.59M
-822.00K
-214.00K
EBT excluding unusual items
-1.30M
1.00M
-786.00K
-184.00K
Income tax expense
220.00K
-262.00K
64.00K
-64.00K
Effective tax rate
-15.36%
-16.45%
-7.79%
29.91%
Other operating expenses
-
-
-
-
Net income
-1.95M
2.00M
-972.00K
-34.00K
Net profit margin
-28.54%
40.00%
-15.03%
-0.65%
Earnings per share
-
-
-
-
Interest and investment income
7.00K
-
-
-
Interest expense
-
-3.00K
-7.00K
-16.00K
Net interest expenses
7.00K
-3.00K
-7.00K
-16.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.21M
-910.00K
-778.00K
-503.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps